GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis

NCT03202004 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The decision not to progress the planned Phase 3 studies is a business decision based on the need to prioritise and focus resources within GSK.

Conditions

Psoriasis

Interventions

DRUG: GSK2894512 1% cream
DRUG: Vehicle cream

Sponsor

GlaxoSmithKline

Collaborators

[object Object]
[object Object]
[object Object]